Healthcare providers urged the DEA to allow virtual prescribing of controlled substances without in-person requirements, advocating for streamlined regulations.At the United States Drug Enforcement Agency’s (DEA) listening sessions on September 12 and 13, healthcare stakeholders argued for permanently extending pandemic-era telehealth prescribing flexibilities for controlled substances.During the COVID-19 pandemic, the DEA waived rules outlined in […]
